Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sebban

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphomaJ Gabarre, E Lepage, A Thyss, et al.
Blood|November 10, 1998
The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma GroupJ Blay, F Gomez, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patientsC Dumontet, J Jaubert, C Sebban, et al.
British Journal of Cancer|September 15, 2001
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomasI Ray-Coquard, H Ghesquière, T Bachelot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
The British Journal of Dermatology|June 13, 2008
Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B-cell lymphomaE Bathelier, L Thomas, B Balme, et al.
Presse Medicale (Paris, France : 1983)|June 1, 1985
[Histological transformation of low malignancy lymphoproliferative syndromes. Clinical and developmental study of 32 cases]B Coiffier, C Sebban, F Berger, et al.
Journal of the American Academy of Dermatology|July 30, 1999
Primary cutaneous marginal zone B-cell lymphoma: a report of 9 casesA de la Fouchardière, B Balme, B Chouvet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic LeukemiaC Sebban, E Lepage, J P Vernant, et al.
Cancer|August 15, 1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapyN Milpied, C Gisselbrecht, J L Harousseau, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphomaJ Gabarre, E Lepage, A Thyss, et al.
Blood|November 10, 1998
The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma GroupJ Blay, F Gomez, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patientsC Dumontet, J Jaubert, C Sebban, et al.
British Journal of Cancer|September 15, 2001
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomasI Ray-Coquard, H Ghesquière, T Bachelot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
The British Journal of Dermatology|June 13, 2008
Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B-cell lymphomaE Bathelier, L Thomas, B Balme, et al.
Presse Medicale (Paris, France : 1983)|June 1, 1985
[Histological transformation of low malignancy lymphoproliferative syndromes. Clinical and developmental study of 32 cases]B Coiffier, C Sebban, F Berger, et al.
Journal of the American Academy of Dermatology|July 30, 1999
Primary cutaneous marginal zone B-cell lymphoma: a report of 9 casesA de la Fouchardière, B Balme, B Chouvet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic LeukemiaC Sebban, E Lepage, J P Vernant, et al.
Cancer|August 15, 1990
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapyN Milpied, C Gisselbrecht, J L Harousseau, et al.
Pageof 15